Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma

Molecular Immunology

Volumn 34, Issue 16-17, 1997, Pages 1157-1165

  Nicholson, Ian C ^a,d   Lenton, Kelly A ^b   Little, Debbie J ^a   Decorso, Tina ^b   Lee, Fook Thean ^c   Scott, Andrew M ^c   Zola, Heddy ^a,e   Hohmann, Arthur W ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d BABRAHAM INSTITUTE   (United Kingdom)

^e CHILD HEALTH RESEARCH INSTITUTE   (Australia)

Author keywords

Antibody therapy; CD19; Leukaemia; Lymphoma; ScFv

Indexed keywords

CD19 ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDOMA; IMMUNOGENICITY; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTHERAPY; LYMPHOBLASTOID CELL LINE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0344157387     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00144-2     Document Type: Article

References (46)

1. Antoniw, P., Farnsworth, A. P., Turner, A., Haines, A. M., Mountain, A., Mackintosh, J., Shochat, D., Humm, J., Welt, S., Old, L. J., Yarranton, G. T. and King, D. J. (1996) Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM). Br. J. Cancer 74, 513-524.
2. Bebbington C. (1995) Expression of antibody genes in mammalian cells. In Monoclonal Antibodies - The second generation, ed. H. Zola, p. 165. Bios Scientific Publishers, Oxford.
3. Begent, R. H., Verhaar, M. J., Chester, K. A., Casey, J. L., Green, A. J., Napier, M. P., Hope-Stone, L. D., Cushen, N., Keep, P. A., Johnson, C. J., Hawkins, R. E., Hilson, A. J. and Robson, L. (1996) Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat. Med. 2, 979-984.
4. Bejcek, B. E., Wang, D., Berven, E., Pennell, C. A., Peiper, S. C., Poppema, S., Uckun, F. M. and Kersey, J. H. (1995) Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen. Cancer Res. 5585, 2346-2351.
5. 125I-containing acylating agent. Biochem., J. 133, 529-539.
6. Carroll, W. L., Mendel, E. and Levy, S. (1988) Hybridoma fusion cell lines contain an aberrant κ transcript. Mol. Immunol. 25, 991-995.
7. Carter, P., Bedouelle, H. and Winter, G. (1985) Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nucleic Acids Res. 13, 4431-4443.
8. Casey, J. L., King, D. J., Chaplin, L. C., Haines, A. M., Pedley, R. B., Mountain, A., Yarranton, G. T. and Begent, R. H. (1996) Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab′ fragments. Br. J. Cancer 14, 1397-1405.
9. Clacksori, T., Gussow, D. and Jones, P. T. (1991) General applications of PCR to gene cloning and manipulation. In PCR. A practical approach, eds M. J. McPherson, P. Quirke and G. R. Taylor, Ch.12. IRL Press, Oxford.
10. Dorken, B., Moller, P., Pezzutto, A., Schwartz-Albiez, R. and Moldenhauer, G. (1989) B cell antigens: CD19. In Leucocyte Typing IV White Cell Differentiation Antigens, eds W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein and A. E. G. K. von dem Born, p. 34. Oxford University Press, Oxford.
11. Evan, G I., Lewis, G. K., Ramsay, G. and Bishop, J. M. (1985) Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell Biol. 5, 3610-3616.
12. Gavilondo-Cowley, J. V., Coloma, M. J., Vazquez, J., Ayala, M., Macias, A., Fry, K. E. and Larrick, J. W. (1990) Specific amplification of rearranged immunoglobulin variable region genes from mouse hybridoma cells. Hybridoma 9, 407-417.
13. Ghetie, M. A., Picker, L. J., Richardson, J. A., Tucker, K., Uhr, J. W. and Vitetta, E. S. (1994) Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest. Blood 83, 1329-1336.
14. Ghetie, M. A. and Vitetta, E. S. (1994) Recent developments in immunotoxin therapy. Curr. Opin. Immunol 6, 707-714.
15. Grossbard, M. L., Lambert, J. M., Goldmacher, V. S., Spector, N. L., Kinsella, J., Eliseo, L., Coral, F., Taylor, J. A., Blattler, W. A., Epstein, C. L. et al (1993) Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms. J. Clin. Oncol. 11, 726-737.
16. Hale, G., Dyer, M. J., Clark, M. R., Phillips, J. M., Marcus, R., Riechmann, L., Winter, G. and Waldmann, H. (1988) Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 2, 1394-1399.
17. Hartmann, F., Renner, C., Jung, W., Deisting, C., Juwana, M., Eichentopf, B., Kloft, M. and Pfreundschuh, M. (1997) Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody. Blood 89, 2042-2047.
18. Hekman, A., Honselaar, A., Vuist, W. M., Sein, J. J., Rodenhuis, S., ten Bokkel Huinink, W. W., Somers, R., Rumke, P. and Melief, C. J. (1991) Initial experience with treatment of human B cell lymphoma with anti-CD 19 monoclonal antibody. Cancer Immunol Immunother. 32, 364-372.
19. Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P. and Winter, G. (1991) Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19, 4133-4137.
20. Irving, R. and Hudson, P. (1995) Superseding hybridoma technology with phage display libraries. In Monoclonal antibodies-The second generation, ed. H. Zola, p. 119. Bios Scientific Publishers, Oxford.
21. Jansen, B., Uckun, F. M., Jaszcz, W. B. and Kersey, J. H. (1992) Establishment of a human t(4; 11) leukemia in severe combined immunodeficient mice and successful treatment using anti-CD19 (B43)-pokeweed antiviral protein immunotoxin. Cancer Res. 52, 406-412.
22. Jespers, L. S., Roberts, A., Mahler, S. M., Winter, G. and Hoogenboom, H. R. (1994) Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology N.Y. 12, 899-903.
23. Lee, F. T., Boniface, G. R., Lambrecht, R. M., Rylatt, D. B. and Bundesen, P. G. (1993) Technetium-99 m labelling of DD-3B6/22 antifibrin monoclonal antibody fragment Fab′ for thrombus imaging. Immunol. Cell Biol. 71, 117-124.
24. Leung, S. O., Dion, A. S., Pellegrini, M. C., Goldenberg, D. M. and Hansen, H. J. (1993) An extended primer set for PCR amplification of murine κ variable regions. Biotechniques 15, 286-292.
25. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J. and Bunn, P. A. J. (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods 72, 77-89.
26. LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J. and Khazaeli, M. B. (1989) Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci. U.S.A. 86, 4220-4224.
27. Meeker, T. C., Miller, R. A., Link, M. P., Bindl, J., Warnke, R. and Levy, R. (1984) A unique human B lymphocyte antigen defined by a monoclonal antibody. Hybridoma 3, 305-320.
28. Milenic, D. E., Yokota, T., Filpula, D. R., Finkelman, M. A., Dodd, S. W., Wood, J. F., Whitlow, M., Snoy, P. and Schlom, J. (1991) Construction, binding properties, metabolism and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. 51, 6363-6371.
29. Nadler, L. M., Anderson, K. C., Marti, G., Bates, M., Park. E., Daley, J. F. and Schlossman, S. F. (1983) B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated and malignant B lymphocytes. J. Immunol. 131, 244-250.
30. Orlandi, R., Gussow, D. H., Jones, P. T. and Winter, G. (1989) Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 86, 3833-3837.
31. Pack, P., Kujau, M., Schroeckh, V., Knupfer, U., Wenderoth, R., Riesenberg, D. and Pluckthun, A. (1993) Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermsntation of Escherichia coli. Biotechnology N.Y. 11, 1271-1277.
32. Pedersen, J. T., Henry, A. H., Searle, S. J., Guild, B. C. Roguska, M. and Rees, A. R. (1994) Comparison of surface accessible residues in human and murine immunoglobulin Fv domains. Implication for humanization of murine antibodies. J. Mol. Biol. 235, 959-973.
33. Pezzutto, A., Dorken, B., Rabinovitch, P. S., Ledbetter, J. A., Moldenhauer, G. and Clark, E. A. (1987) CD 19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol. 138, 2793-2799.
34. Pietersz, G. A. and McKenzie, I. F. (1992) Antibody conjugates for the treatment of cancer. Immunol. Rev. 129, 57-80.
35. Pietersz, G. A., Wenjun, L., Sutton, V. R., Burgess, J., McKenzie, I. F., Zola, H. and Trapani, J. A. (1995) In vitro and in vivo antitumor activity of a chimeric anti-CD19 antibody. Cancer Immunol Immunother. 41, 53-60.
36. Renner, C., Bauer, S., Sahin, U., Jung, W., van Lier, R., Jacobs, G., Held, G. and Pfreundschuh, M. (1996) Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model. Blood 87, 2930-2937.
37. Roguska, M. A., Pedersen, J. T., Keddy, C. A., Henry, A. H., Searle, S. J., Lambert, J. M., Goldmacher, V. S., Blattler, W. A., Rees, A. R. and Guild, B. C. (1994) Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc. Natl. Acad. Sci. U.S.A. 91, 969-973.
38. Rosok, M. J., Yelton, D. E., Harris, L. J., Bajorath, J., Hellstrom, K. E., Hellstrom, I., Cruz, G. A., Kristensson, K., Lin, H., Huse, W. D. and Glaser, S. M. (1996) A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab. J. Biol. Chem. 271, 22611-22618.
39. Stone, M. J., Sausville, E. A., Fay, J. W., Headlee, D., Collins, R. H., Figg, W. D., Steuer Stevenson, M., Jain, V., Jaffe, E. S., Solomon, D., Lush, R. M., Senderowicz, A., Ghetie, V., Schindler, J., Uhr, J. W. and Vitetta, E. S. (1996) A phase 1 study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. Blood 88, 1188-1197.
40. Uckun, F. M., Jaszcz, W., Ambrus, J. L., Fauci, A. S., Gajl-Peczalska, K., Song, C. W., Wick, M. R., Myers, D. E., Waddick, K. and Ledbetter, J. A. (1988) Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood 71, 13-29.
41. Vlasveld, L. T., Hekman, A., Vyth-Dreese, F. A., Melief, C. J., Sein, J. J., Voordouw, A. C., Dellemijn, T. A. and Rankin, E. M. (1995) Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19. Cancer Immunol. Immunother. 40, 37-47.
42. Wels, W., Harwerth, I. M., Mueller, M., Groner, B. and Hynes, N. E. (1992) Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res. 52, 6310-6317.
43. Winter, G., Griffiths, A. D., Hawkins, R. E. and Hoogenboom, H. R. (1994) Making Antibodies by Phage Display Technology. Ann. Rev. Immunol. 12, 433-455.
44. Yokota, T., Milenic, D. E., Whitlow, M. and Schlom, J. (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402-3408.
45. Zola, H., Macardle, P. J., Bradford, T., Weedon, H., Yasui, H. and Kurosawa, Y. (1991) Preparation and characterization of a chimeric CD 19 monoclonal antibody. Immunol. Cell Biol. 69, 411-422.
46. Zola, H., Ridings, J., Weedon, H., Fusco, M., Byard, R. W. and Macardle, P. J. (1995) Cytokine receptor expression in human lymphoid tissue: analysis by fluorescence microscopy. Disease Markers 12, 147-165.